哪些ETF持有 GLAXO.NS?
GlaxoSmithKline Pharmaceuticals Ltd — 5 ETF持有，市值 $21.3M 覆盖 758.88K 股份.
持仓数据截至 Aug 26, 2026 — 数据提供商报告的投资组合日期；非实时仓位。
| # | ETF | 权重 | 股票 | 价值 | ETF资产规模 | 类别 | 今日 | |
|---|---|---|---|---|---|---|---|---|
| 1 | VEXC Vanguard Emerging Markets Ex-China ETF | 0.02% | 1.44K | $40.0K | $257.8M | Emerging Markets | +0.59% | |
| 2 | SCHE Schwab Emerging Markets Equity ETF | 0.01% | 50.67K | $1.6M | $12.91B | Emerging Markets | +0.46% | |
| 3 | VWO Vanguard FTSE Emerging Markets ETF | 0.01% | 601.45K | $16.7M | $162.30B | Emerging Markets | +0.59% | |
| 4 | VSGX Vanguard ESG International Stock ETF | 0.00% | 7.55K | $210.0K | $6.50B | Developed Markets | +0.10% | |
| 5 | VEU Vanguard FTSE All-World ex-US ETF | 0.00% | 97.78K | $2.7M | $95.90B | Developed Markets | +0.06% |
覆盖范围反映数据库中已加载的ETF投资组合；极小型基金可能尚未完成采集。 Market data delayed approximately 15–20 minutes unless otherwise indicated.